By 2025, sPAP was higher in COPD, whereas MR-proANP remained consistently higher in SSc-ILD, highlighting distinct patterns of vascular–neurohumoral dysregulation. The gene discussed is NPPA; the disease is chronic obstructive pulmonary disease.